traJ Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
traJ antibody; Protein TraJ antibody
Target Names
traJ
Uniprot No.

Target Background

Function
TraJ antibody is essential for positively regulating the expression of transfer genes involved in the conjugal transfer of DNA between bacterial cells.
Subcellular Location
Cell membrane; Peripheral membrane protein.

Q&A

What are the validated applications for traJ antibody in experimental protocols?

The rabbit polyclonal traJ antibody has been rigorously validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . For Western blotting, researchers should optimize protein loading (typically 20-50μg total protein) and primary antibody concentration (starting with 1:1000 dilution) to achieve optimal signal-to-noise ratio. When designing ELISA protocols, consider that traJ antibody performs optimally in indirect ELISA formats with overnight primary antibody incubation at 4°C. This approach aligns with general antibody optimization strategies used in comparative studies of other antibody systems .

What storage and handling protocols ensure optimal traJ antibody performance?

To maintain antibody activity, store traJ antibody at -20°C or -80°C immediately upon receipt . The antibody is supplied in liquid form with 50% glycerol and 0.03% Proclin 300 as preservatives . Critically, researchers should avoid repeated freeze-thaw cycles, as this can significantly degrade antibody performance through fragmentation and aggregation. When designing multi-week experimental timelines, consider preparing small working aliquots (10-20μL) to minimize freeze-thaw cycles, similar to preservation strategies employed in longitudinal antibody studies .

What positive and negative controls should be incorporated when working with traJ antibody?

The commercially available traJ antibody is supplied with 200μg recombinant immunogen protein/peptide that serves as an effective positive control . For robust experimental design, researchers should include:

  • Positive control: The supplied recombinant traJ protein/peptide

  • Negative controls:

    • Isotype control (rabbit IgG) to assess non-specific binding

    • E. coli strains with confirmed traJ deletion

    • Secondary antibody-only controls to assess background

This multi-control approach follows best practices identified in comparative antibody studies and helps differentiate specific signals from experimental artifacts .

How can epitope specificity of traJ antibody be verified in experimental settings?

Verification of epitope specificity requires a multi-method approach:

  • Peptide competition assay: Pre-incubate traJ antibody with excess immunizing peptide before application in Western blot or ELISA. Signal abolishment confirms specificity.

  • CRISPR/Cas9 knockout validation: Generate traJ knockout E. coli strains and confirm loss of signal.

  • Orthogonal method comparison: Correlate antibody detection with mRNA expression via RT-qPCR.

  • Mass spectrometry validation: Perform immunoprecipitation followed by LC-MS/MS to confirm target identity.

These methods parallel validation approaches used in other antibody systems and ensure experimental rigor .

What factors affect traJ antibody binding efficiency in complex bacterial samples?

Multiple factors can influence binding efficiency:

FactorImpact on BindingOptimization Strategy
Sample preparationProtein conformation may be alteredTest multiple lysis buffers (RIPA, NP-40, etc.)
Blocking agentsMay cause epitope maskingCompare BSA vs. milk-based blockers
Incubation timeInsufficient time leads to weak signalOptimize between 1-16 hours at 4°C
Detergent concentrationMay interfere with bindingTitrate Tween-20 (0.05-0.1%)
Bacterial growth phaseVariable traJ expressionStandardize culture conditions

These considerations align with general principles of antibody optimization in microbiology research and help ensure consistent results across experiments .

How should researchers interpret variable traJ antibody signals across experimental replicates?

Variability in signal intensity requires systematic troubleshooting:

  • Quantify coefficient of variation (CV) across technical and biological replicates. CV values >15% indicate problematic variability.

  • Implement internal loading controls for normalization (e.g., housekeeping proteins for Western blot, standard curves for ELISA).

  • Apply appropriate statistical tests based on data distribution (typically non-parametric tests for antibody-based assays).

  • Consider using latent class growth mixture modeling (LCGMM) to identify distinct patterns in longitudinal experiments, similar to approaches used in antibody trajectory studies .

  • Standardize signal quantification methods (e.g., densitometry for Western blots) and perform calibration with known quantities of recombinant protein.

This analytical framework ensures robust interpretation of antibody signals and aligns with advanced statistical approaches used in immunological research .

What statistical approaches are recommended for quantifying traJ protein expression using antibody-based detection?

For rigorous quantification:

  • Implement standard curve calibration using the supplied recombinant protein (200μg) .

  • Apply four-parameter logistic regression (4PL) for ELISA quantification to account for sigmoidal dose-response relationships.

  • For Western blot densitometry:

    • Use local background subtraction

    • Apply rolling ball algorithm for background estimation

    • Verify linear range of detection

    • Normalize to housekeeping proteins

  • Consider Spearman correlation and Passing-Bablok regression analysis when comparing different detection methods, similar to approaches used in comparative antibody assay studies .

  • For longitudinal studies tracking traJ expression, multinomial logistic regression models can identify factors associated with different expression patterns, as demonstrated in antibody trajectory research .

How does polyclonal traJ antibody performance compare to other detection methods in bacterial conjugation studies?

The polyclonal nature of commercially available traJ antibody offers distinct advantages and limitations:

MethodSensitivitySpecificityThroughputResource Requirements
Polyclonal traJ antibodyHighModerateModerateModerate
qRT-PCR for traJ mRNAHighHighHighModerate
Recombinant tagged traJVariableHighLowHigh
Mass spectrometryVery highVery highLowVery high

Polyclonal antibodies recognize multiple epitopes, enhancing sensitivity but potentially introducing cross-reactivity. This parallels observations in comparative antibody studies where trade-offs between sensitivity and specificity were observed . Researchers should validate findings with orthogonal methods when possible.

What methodological considerations apply when using traJ antibody in combination with other bacterial conjugation markers?

When designing multiplexed detection systems:

  • Consider epitope accessibility in protein complexes

  • Test for potential antibody cross-reactivity

  • Optimize fixation methods for immunofluorescence studies

  • When performing co-immunoprecipitation, test interaction buffers of varying stringency

  • For multi-color immunofluorescence, ensure spectral separation of fluorophores

These considerations follow established principles in complex antibody applications such as those used in TrkB antibody immunofluorescence protocols .

How can researchers optimize traJ antibody protocols for low-abundance targets?

For detecting low-abundance traJ protein:

  • Signal amplification strategies:

    • Implement tyramide signal amplification (TSA)

    • Consider polymer-based detection systems

    • Use high-sensitivity chemiluminescent substrates for Western blots

  • Sample enrichment approaches:

    • Immunoprecipitation before Western blotting

    • Subcellular fractionation to concentrate target

    • Optimize bacterial growth conditions to upregulate traJ expression

  • Blocking optimization:

    • Test various blocking agents (BSA, casein, commercial blockers)

    • Optimize blocking time and temperature

    • Consider adding 0.1-0.3% Triton X-100 to reduce background

These approaches align with sensitivity enhancement strategies utilized in other antibody systems and can significantly improve detection of challenging targets .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.